Neuroinflammation and Depression: The Role of Indoleamine 2,3-dioxygenase (IDO) as a Molecular Pathway
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Department of Molecular Imaging and Neuropathology New York State Psychiatric Institute New York, NY Department of Psychiatry Columbia University New York, NY Mood and Anxiety Program, Department of Psychiatry School of Medicine, University of Maryland Baltimore, Maryland Veterans Administration Capitol Health Care Network (VISN 5) Mental Illness Research, Education and Clinical Center Baltimore, MD E-mail: [email protected]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · cited 1×
“symptoms is correlated with measures of IDO activity but not with measures of TRP availability to the brain (8) and that elevated cerebrospinal fluid KYN metabolites are not associated with depleted cerebrospinal fluid TRP (21).”
BackgroundMaes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Mann, J. J., Huang, Y.-Y., Underwood, M. D., Kassir, S. A., Oppenheim, S., Kelly, T. M., Dwork, A. J., & Arango, V. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.729 · Cited by 613
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568 · cited 1×
“as the subgenual prefrontal cortex and anterior midcingulate cortex (36).”
BackgroundLindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., Hansson, O., Björkqvist, M., Träskman-Bendz, L., & Brundin, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.030 · Cited by 524
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 1×
“rotonergic functioning (13) and low TRP levels (14) are both”
BackgroundWichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445 · cited 2×
“symptoms is correlated with measures of IDO activity but not with measures of TRP availability to the brain (8) and that elevated cerebrospinal fluid KYN metabolites are not associated with depleted cerebrospinal fluid TRP (21).”
BackgroundEffects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370
Capuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., Layé, S., & Fuchs, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.006 · Cited by 368 · cited 1×
“which can occur along with IDO activation, is also induced by inflammatory mediators, can lead to deficiencies in norepinephrine and dopamine in addition to serotonin, and has been recently associated in older adults with low energy, insomnia, and other neurovegetative symptoms of depression (54).”
BackgroundFrommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Cytokine levels in the blood may distinguish suicide attempters from depressed patients
Janelidze, S., Mattei, D., Westrin, Å., Träskman-Bendz, L., & Brundin, L. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.10.010 · Cited by 298
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289 · cited 1×
“and microglia activation (2); and increased circulating levels of inflammation markers such as C-reactive protein (CRP) levels (3) and proinflammatory cytokines, as well as their soluble receptors, including interleukin 2 (IL-2), soluble IL-2 receptor, IL-1b, IL-1 receptor antagonist, IL-6, soluble IL-6 receptor, inte…”
BackgroundChronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Neurauter, G., Schrocksnadel, K., Scholl-Burgi, S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., & Fuchs, D. (2008) · Current Drug Metabolism · doi:10.2174/138920008785821738 · Cited by 274
Neumeister, A., Nugent, A. C., Waldeck, T., Geraci, M., Schwarz, M., Bonne, O., Bain, E. E., Luckenbaugh, D. A., Herscovitch, P., Charney, D. S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.765 · Cited by 273 · cited 1×
“Reemergence of depressive symptoms induced by TRP depletion also has been correlated with functional changes in brain regions involved in mood regulation and dysregulation (18), and both the increased symptoms (19) and brain metabolic changes (20) are differentially associated with the s/s variant of the serotonin tra…”
BackgroundElevated Cytokine Expression in the Orbitofrontal Cortex of Victims of Suicide
Tonelli, L. H., Stiller, J., Rujescu, D., Giegling, I., Schneider, B., Maurer, K., Schnabel, A., Möller, H. ‐., Chen, H. H., & Postolache, T. T. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01128.x · Cited by 252
Self-citationPlasma kynurenine levels are elevated in suicide attempters with major depressive disorder
Sublette, M. E., Galfalvy, H. C., Fuchs, D., Lapidus, M., Grunebaum, M. F., Oquendo, M. A., John Mann, J., & Postolache, T. T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.05.002 · Cited by 250 · cited 2×
“levels of the cytokine activation marker neopterin (31), con-”
BackgroundSelf-citationNeumeister, A., Konstantinidis, A., Stastny, J., Schwarz, M. J., Vitouch, O., Willeit, M., Praschak-Rieder, N., Zach, J., de Zwaan, M., Bondy, B., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.613 · Cited by 223
Neumeister, A., Hu, X.-Z., Luckenbaugh, D. A., Schwarz, M., Nugent, A. C., Bonne, O., Herscovitch, P., Goldman, D., Drevets, W. C., & Charney, D. S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.9.978 · Cited by 161 · cited 1×
“Reemergence of depressive symptoms induced by TRP depletion also has been correlated with functional changes in brain regions involved in mood regulation and dysregulation (18), and both the increased symptoms (19) and brain metabolic changes (20) are differentially associated with the s/s variant of the serotonin tra…”
BackgroundKynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Muller, N., Myint, A.-M., & J. Schwarz, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049552 · Cited by 94 · cited 1×
“We note as well that the KYN pathways are not uniquely related to depression; there is growing evidence, for instance, for their involvement in schizophrenia (57,58).”
BackgroundSmith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Tryptophan Depletion and Emotional Processing in Healthy Volunteers at High Risk for Depression
Feder, A., Skipper, J., Blair, J. R., Buchholz, K., Mathew, S. J., Schwarz, M., Doucette, J. T., Alonso, A., Collins, K. A., Neumeister, A., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.033 · Cited by 44 · cited 1×
“depression (15) and depressive relapse among remitted de-”
Background
Cited by
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms
Penninx, B. W. J. H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.07.003 · Cited by 576
Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Penninx, B. W. J. H., & Lange, S. M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/bpenninx · Cited by 566
Zhao, X., Cao, F., Liu, Q., Li, X., Xu, G., Liu, G., Zhang, Y., Yang, X., Yi, S., Xu, F., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.064 · Cited by 280
The serotonergic system in mood disorders and suicidal behaviour
Mann, J. J. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0537 · Cited by 235
Metadata
- Authors
- Sublette, M. E., & Postolache, T. T.
- Venue
- Psychosomatic Medicine
- Published
- 2012-09
- Volume
- 74
- Issue
- 7
- Pages
- 668-672
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2086410696
- Cited by
- 72
- References
- 25
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.